Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.00005 par value
-
Shares outstanding
-
7,182,182
-
Total 13F shares
-
2,317
-
Share change
-
-233,437
-
Total reported value
-
$1,727
-
Price per share
-
$0.71
-
Number of holders
-
5
-
Value change
-
-$261,340
-
Number of sells
-
27
Institutional Holders of BRAINSTORM CELL THERAPEUTICS INC. - Common Stock, $0.00005 par value (BCLI) as of Q3 2025
As of 30 Sep 2025,
BRAINSTORM CELL THERAPEUTICS INC. - Common Stock, $0.00005 par value (BCLI) was held by
5 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,317 shares.
The largest 5 holders included
OSAIC HOLDINGS, INC., Bangor Savings Bank, VSM Wealth Advisory, LLC, Steward Partners Investment Advisory, LLC, and ST GERMAIN D J CO INC.
This page lists
5
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.